Ansell Limited (ANSLY)
USD 71.79
(0.0%)
USD 71.79
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 495.5 Million USD | 21.64% |
| 2023 | 407.35 Million USD | 4.03% |
| 2022 | 391.57 Million USD | -15.5% |
| 2021 | 463.38 Million USD | 8.95% |
| 2020 | 425.32 Million USD | 14.63% |
| 2019 | 371.04 Million USD | 3.82% |
| 2018 | 357.38 Million USD | 0.17% |
| 2017 | 356.78 Million USD | 9.26% |
| 2016 | 326.54 Million USD | -12.97% |
| 2015 | 375.2 Million USD | -19.11% |
| 2014 | 463.81 Million USD | 30.2% |
| 2013 | 356.23 Million USD | -7.69% |
| 2012 | 385.9 Million USD | -4.93% |
| 2011 | 405.9 Million USD | 43.65% |
| 2010 | 282.56 Million USD | 6.87% |
| 2009 | 264.39 Million USD | -27.73% |
| 2008 | 365.85 Million USD | 41.5% |
| 2007 | 258.56 Million USD | 52.58% |
| 2006 | 169.45 Million USD | -9.17% |
| 2005 | 186.56 Million USD | 12.69% |
| 2004 | 165.55 Million USD | -14.55% |
| 2003 | 193.73 Million USD | -1.09% |
| 2002 | 195.86 Million USD | 434.11% |
| 2001 | 36.67 Million USD | 9.1% |
| 2000 | 33.61 Million USD | -75.22% |
| 1999 | 135.65 Million USD | 59.56% |
| 1998 | 85.02 Million USD | 101.85% |
| 1997 | -4.59 Billion USD | 4.59% |
| 1996 | -4.81 Billion USD | 3.37% |
| 1995 | -4.98 Billion USD | -2.7% |
| 1994 | -4.85 Billion USD | -19.54% |
| 1993 | -4.05 Billion USD | 2.52% |
| 1992 | -4.16 Billion USD | -14.15% |
| 1991 | -3.64 Billion USD | 6.13% |
| 1990 | -3.88 Billion USD | -16.56% |
| 1989 | -3.33 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 425.4 Million USD | 4.43% |
| 2024 Q4 | 233.37 Million USD | 97.44% |
| 2024 Q3 | 118.2 Million USD | -53.99% |
| 2024 Q2 | 256.89 Million USD | 97.01% |
| 2024 Q1 | 130.4 Million USD | -31.68% |
| 2023 FY | 407.35 Million USD | 4.03% |
| 2023 Q1 | 107.9 Million USD | -50.1% |
| 2023 Q2 | 209.8 Million USD | 94.44% |
| 2023 Q3 | 97.55 Million USD | -53.5% |
| 2023 Q4 | 190.87 Million USD | 95.67% |
| 2022 FY | 391.57 Million USD | -15.5% |
| 2022 Q4 | 216.21 Million USD | 0.0% |
| 2022 Q2 | 208.5 Million USD | 0.0% |
| 2021 Q4 | 234.58 Million USD | 0.0% |
| 2021 FY | 463.38 Million USD | 8.95% |
| 2021 Q2 | 229.5 Million USD | 0.0% |
| 2020 Q2 | 200.3 Million USD | 0.0% |
| 2020 Q4 | 194.83 Million USD | 0.0% |
| 2020 FY | 425.32 Million USD | 14.63% |
| 2019 Q4 | 190.29 Million USD | 0.0% |
| 2019 FY | 371.04 Million USD | 3.82% |
| 2019 Q2 | 306.37 Million USD | 0.0% |
| 2018 Q2 | 267.7 Million USD | 0.0% |
| 2018 FY | 357.38 Million USD | 0.17% |
| 2018 Q4 | 297.37 Million USD | 0.0% |
| 2017 Q2 | 247.91 Million USD | 0.0% |
| 2017 FY | 356.78 Million USD | 9.26% |
| 2017 Q4 | 243.95 Million USD | 0.0% |
| 2016 Q2 | 295.08 Million USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | 326.54 Million USD | -12.97% |
| 2015 Q4 | 281.3 Million USD | 0.0% |
| 2015 Q2 | 295.85 Million USD | 0.0% |
| 2015 FY | 375.2 Million USD | -19.11% |
| 2014 Q1 | 92.22 Million USD | -60.31% |
| 2014 Q2 | 244.31 Million USD | 164.93% |
| 2014 Q3 | 98.05 Thousand USD | -99.96% |
| 2014 FY | 463.81 Million USD | 30.2% |
| 2014 Q4 | 388.83 Million USD | 396426.93% |
| 2013 Q4 | 232.34 Million USD | 125.86% |
| 2013 FY | 356.23 Million USD | -7.69% |
| 2013 Q1 | 91.18 Million USD | 0.0% |
| 2013 Q2 | 102.85 Million USD | 12.8% |
| 2013 Q3 | 102.87 Million USD | 0.02% |
| 2012 Q2 | 93.87 Million USD | 5653.7% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | 385.9 Million USD | -4.93% |
| 2012 Q1 | 1.63 Million USD | 0.0% |
| 2012 Q3 | 91.15 Million USD | -2.9% |
| 2011 Q1 | 89.2 Million USD | 0.0% |
| 2011 FY | 405.9 Million USD | 43.65% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 1.73 Million USD | 3.95% |
| 2011 Q2 | 1.66 Million USD | -98.13% |
| 2010 FY | 282.56 Million USD | 6.87% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 84.69 Million USD | 3.18% |
| 2010 Q1 | 82.37 Million USD | 0.0% |
| 2010 Q2 | 82.08 Million USD | -0.36% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | 264.39 Million USD | -27.73% |
| 2009 Q1 | 70.2 Million USD | 0.0% |
| 2009 Q2 | 61.18 Million USD | -12.84% |
| 2009 Q3 | 66.93 Million USD | 9.4% |
| 2008 FY | 365.85 Million USD | 41.5% |
| 2008 Q3 | 83.54 Million USD | 2.02% |
| 2008 Q2 | 81.88 Million USD | 37.21% |
| 2008 Q1 | 59.67 Million USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q1 | 53.14 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 54.7 Million USD | 4.45% |
| 2007 Q2 | 52.37 Million USD | -1.46% |
| 2007 FY | 258.56 Million USD | 52.58% |
| 2006 FY | 169.45 Million USD | -9.17% |
| 2006 Q1 | 52.78 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | 53.3 Million USD | 1.0% |
| 2006 Q3 | 50.5 Million USD | -5.26% |
| 2005 Q1 | 60.73 Million USD | 0.0% |
| 2005 FY | 186.56 Million USD | 12.69% |
| 2005 Q2 | 53.71 Million USD | -11.55% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 53.5 Million USD | -0.39% |
| 2004 FY | 165.55 Million USD | -14.55% |
| 2004 Q2 | 64.48 Million USD | 3.0% |
| 2004 Q1 | 62.6 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 63.88 Million USD | -0.93% |
| 2003 FY | 193.73 Million USD | -1.09% |
| 2003 Q2 | 53.87 Million USD | -25.81% |
| 2003 Q1 | 72.62 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q3 | 55.04 Million USD | 2.16% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q3 | 70.9 Million USD | 4.45% |
| 2002 FY | 195.86 Million USD | 434.11% |
| 2002 Q1 | 338.39 Million USD | 0.0% |
| 2002 Q2 | 67.88 Million USD | -79.94% |
| 2001 Q1 | 12.26 Million USD | 0.0% |
| 2001 FY | 36.67 Million USD | 9.1% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 337.06 Million USD | -10.97% |
| 2001 Q2 | 378.6 Million USD | 2987.75% |
| 2000 FY | 33.61 Million USD | -75.22% |
| 2000 Q1 | 49.16 Million USD | 0.0% |
| 2000 Q3 | 13.7 Million USD | -5.61% |
| 2000 Q2 | 14.51 Million USD | -70.47% |
| 2000 Q4 | - USD | -100.0% |
| 1999 Q4 | - USD | -100.0% |
| 1999 FY | 135.65 Million USD | 59.56% |
| 1999 Q3 | 47.38 Million USD | 0.27% |
| 1999 Q1 | 33.13 Million USD | 0.0% |
| 1999 Q2 | 47.25 Million USD | 42.61% |
| 1998 Q4 | - USD | -100.0% |
| 1998 FY | 85.02 Million USD | 101.85% |
| 1998 Q3 | 36.66 Million USD | -3.21% |
| 1998 Q1 | 15.32 Million USD | 0.0% |
| 1998 Q2 | 37.88 Million USD | 147.21% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 16.55 Million USD | 2.31% |
| 1997 Q1 | -57.12 Million USD | -0.2% |
| 1997 FY | -4.59 Billion USD | 4.59% |
| 1997 Q2 | 16.17 Million USD | 128.32% |
| 1996 Q1 | -57.13 Million USD | -5.73% |
| 1996 FY | -4.81 Billion USD | 3.37% |
| 1996 Q2 | -54.22 Million USD | 5.09% |
| 1996 Q3 | -56.43 Million USD | -4.06% |
| 1996 Q4 | -57.01 Million USD | -1.03% |
| 1995 Q3 | -55.33 Million USD | 3.37% |
| 1995 Q4 | -54.03 Million USD | 2.34% |
| 1995 FY | -4.98 Billion USD | -2.7% |
| 1995 Q1 | -53.78 Million USD | -1.58% |
| 1995 Q2 | -57.26 Million USD | -6.46% |
| 1994 Q1 | -38.77 Million USD | 3.57% |
| 1994 FY | -4.85 Billion USD | -19.54% |
| 1994 Q4 | -52.95 Million USD | -3.49% |
| 1994 Q2 | -51.57 Million USD | -33.01% |
| 1994 Q3 | -51.16 Million USD | 0.8% |
| 1993 Q3 | -42.1 Million USD | -3.72% |
| 1993 Q4 | -40.21 Million USD | 4.5% |
| 1993 FY | -4.05 Billion USD | 2.52% |
| 1993 Q2 | -40.59 Million USD | -11.13% |
| 1993 Q1 | -36.53 Million USD | 3.88% |
| 1992 Q4 | -38 Million USD | 2.8% |
| 1992 FY | -4.16 Billion USD | -14.15% |
| 1992 Q1 | -30.69 Million USD | -3.93% |
| 1992 Q2 | -38.14 Million USD | -24.29% |
| 1992 Q3 | -39.09 Million USD | -2.49% |
| 1991 Q3 | -29.82 Million USD | 1.11% |
| 1991 Q4 | -29.53 Million USD | 0.99% |
| 1991 Q2 | -30.16 Million USD | -15.05% |
| 1991 FY | -3.64 Billion USD | 6.13% |
| 1991 Q1 | -26.21 Million USD | -4.87% |
| 1990 Q1 | -19.93 Million USD | -2.5% |
| 1990 Q2 | -24.37 Million USD | -22.29% |
| 1990 Q3 | -23.8 Million USD | 2.34% |
| 1990 Q4 | -24.99 Million USD | -5.0% |
| 1990 FY | -3.88 Billion USD | -16.56% |
| 1989 Q2 | -22.66 Million USD | 0.0% |
| 1989 FY | -3.33 Billion USD | 0.0% |
| 1989 Q4 | -19.44 Million USD | 7.21% |
| 1989 Q3 | -20.96 Million USD | 7.51% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -17205.044% |
| Ansell Limited | 495.5 Million USD | 0.0% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -498.403% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -28529.108% |
| Psykey, Inc. | 1.21 Million USD | -40732.976% |
| ConvaTec Group Plc | 910.31 Million USD | 45.568% |
| ConvaTec Group Plc | 872.5 Million USD | 43.209% |
| Encision Inc. | 3.77 Million USD | -13019.763% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -349308.72% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -450637.281% |
| Innovative MedTech Inc. | 6.09 Million USD | -8024.281% |
| LifePoint, Inc. | 7.42 Million USD | -6574.416% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -7704.379% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -57853.216% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -68138.094% |
| Reflect Scientific, Inc. | 1.06 Million USD | -46482.727% |
| SmileDirectClub, Inc. | 517 Million USD | 4.159% |
| Sector 10, Inc. | 39.84 Thousand USD | -1243500.04% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 92.541% |
| SheerVision, Inc. | 2.33 Million USD | -21151.182% |
| United Health Products, Inc. | 2.42 Million USD | -20320.03% |
| Vasamed, Inc. | 4.67 Million USD | -10503.662% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -19241.839% |
| Yubo International Biotech Limited | 1.25 Million USD | -39291.831% |